Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot double-blind placebo-controlled study of PSD506 in benign prostatic obstruction with LUTS
2006-002055-32Phase 2Terminated
- Sponsor
- Plethora Solutions
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in benign prostatic obstruction (BPO), benign prostatic hyperplasia (BPH) and Micturition disorder comparing PSD506 with Placebo (2 arms). Primary endpoint: Safety comparison of PSD506 vs placebo using bladder outlet obstruction urodynamic measure. Started Jul 2006; status: terminated.
02
Drugs
PSD506
03
Conditions
benign prostatic obstruction (BPO)benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on 2006-002055-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002055-32.